Fortress Biotech

FBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$81.710 M

$2.45 +1.66%

Close of 22 Sept 2026

Revenue

$63.3M

#2657 by revenue

Earnings

$37.0M

#1681 by earnings

Shares outstanding

33,311,012

Latest filing cover page

P/E ratio

2.2

Cap ÷ net income

Other share classes

Fortress Biotech lists more than one class of stock. Company figures above cover all classes combined.

FBIOP

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#321MAIA BiotechnologyMAIA$83.3M
#322OS TherapiesOSTX$82.3M
#323Fortress BiotechFBIO$81.7M
#324Verrica PharmaceuticalsVRCA$81.1M
#325Spero TherapeuticsSPRO$79.2M

What if Fortress Biotech were worth as much as…

Open the what-if tool →

Gold $30.2T

$906,538.81

Per share 370,016× higher

Bitcoin $1.74T

$52,221.98

Per share 21,315× higher

Nvidia $5.52T

$165,385.39

Per share 67,504× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Fortress Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.